Autres langues Bio-Techne Corporation

Actions

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 02/05/2024			Varia. 5j.	Varia. 1 janv.
75,6 ^USD	+2,91 %		+19,02 %	-2,02 %

02/05	BIO-TECHNE CORPORATION : UBS reste à l'achat	ZM
02/05	BIO-TECHNE CORPORATION : Opinion positive de Leerink Partners	ZM

Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Equity Markets Mostly Fall After Fed Leaves Rate Unchanged	01/05
Top Midday Gainers	01/05
US Equity Indexes Mixed as Investors Look for Clarity in Fed's Policy Path in Presidential Election Year	01/05
US Equity Indexes Mixed Ahead of Fed Policy Statement, Views on Monetary Policy Path for 2024	01/05
Bio-Techne Shares Jump After Fiscal Q3 Beat	01/05
Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise	01/05
Earnings Flash (TECH) BIO-TECHNE CORPORATION Reports Q3 Revenue $303.4M	01/05
BIO-TECHNE DECLARES DIVIDEND	01/05
BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS	01/05
Bio-Techne Corporation Declares Dividend for the Quarter Ended March 31, 2024, Payable on May 24, 2024	01/05
BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS	30/04
Bio-Techne Corporation Appoints Dr. Judith Klimovsky to Board of Directors	30/04
Bio-Techne to Enter Product Distribution Deal With Thermo Fisher Scientific	29/04
BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH THERMO FISHER SCIENTIFIC	29/04
Bio-Techne Corporation Announces New Distribution Agreement with Thermo Fisher Scientific	29/04
BIO-TECHNE AND NOVOMOL-Dx ANNOUNCE POINT-OF-CARE OCULAR BIOMARKER ASSAY	26/04
Bio-Techne Corporation and Novomol-Dx Announce Point-of-Care Ocular Biomarker Assay	26/04
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe	23/04
BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS	23/04

Aucun résultat pour cette recherche